Cardinal Health (CAH) Projected to Announce Earnings on Tuesday

Cardinal Health (NYSE:CAH) is projected to release its Q4 2026 results before the market opens on Tuesday, August 11th. Analysts expect Cardinal Health to announce earnings of $2.42 per share and revenue of $65.1530 billion for the quarter. Investors may review the information on the company’s upcoming Q4 2026 earning report page for the latest details on the call scheduled for Tuesday, August 11, 2026 at 8:30 AM ET.

Cardinal Health Price Performance

NYSE:CAH traded down $0.83 during midday trading on Tuesday, hitting $234.77. The company’s stock had a trading volume of 493,237 shares, compared to its average volume of 2,019,214. Cardinal Health has a fifty-two week low of $137.75 and a fifty-two week high of $243.21. The firm has a market cap of $54.98 billion, a P/E ratio of 35.96, a P/E/G ratio of 1.12 and a beta of 0.49. The firm’s 50 day moving average is $223.64 and its 200-day moving average is $215.58.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Integrated Wealth Concepts LLC boosted its stake in Cardinal Health by 6.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after purchasing an additional 280 shares during the period. Jones Financial Companies Lllp grew its stake in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. Arrowstreet Capital Limited Partnership purchased a new position in Cardinal Health during the second quarter worth $1,935,000. Cerity Partners LLC boosted its stake in shares of Cardinal Health by 17.0% during the second quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock valued at $6,792,000 after acquiring an additional 5,880 shares during the last quarter. Finally, Nebula Research & Development LLC boosted its stake in shares of Cardinal Health by 34.4% during the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock worth $1,736,000 after purchasing an additional 2,646 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CAH has been the subject of several recent research reports. Zacks Research cut shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Evercore lowered their target price on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 8th. UBS Group raised their price objective on shares of Cardinal Health from $260.00 to $274.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. Citigroup lifted their price target on Cardinal Health from $245.00 to $265.00 and gave the company a “buy” rating in a research note on Friday, July 24th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $251.73.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.